Dave Singh

38.9k citations
565 papers · 16.3k · 8 hit papers · h-index 68

Impact in

    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Respiratory Support and Mechanisms
    • Respiratory and Cough-Related Research
    • Inhalation and Respiratory Drug Delivery
    • Neonatal Respiratory Health Research
  • Physiology top 0.1%
    • Asthma and respiratory diseases

Papers in

    • Chronic Obstructive Pulmonary Disease (COPD) Research 324
    • Respiratory Support and Mechanisms 71
    • Respiratory and Cough-Related Research 69
    • Inhalation and Respiratory Drug Delivery 68
    • Neonatal Respiratory Health Research 19
    • Asthma and respiratory diseases 221

Dave Singh

538 papers receiving 16.0k citations

Dave Singh's Hit Papers

Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials 2025 · 26 citations
260+3+6Years since publication250500750

Peers

Dave Singh
Comparison fields: 5 of 161
  • Pulmonary and Respiratory Medicine 10.1k
  • Physiology 5.8k
  • Emergency Medical Services 828
  • Issues, ethics and legal aspects 99
  • Immunology 1.3k
Replace Mario Cazzola with:
Mario Cazzola Italy
Ruth Tal‐Singer United States
Alberto Papi Italy
Huib A.M. Kerstjens Netherlands
Nicola A. Hanania United States
Borja G. Cosío Spain
MeiLan K. Han United States
Robert A. Stockley United Kingdom
Suzanne S. Hurd United States
Gaetano Caramori Italy
Dave Singh relative to Mario Cazzola Italy Mario Cazzola's profile →
Citations per field
00.5×1.5×2.2×
Mario Cazzola · 1×
Citations per year

Countries citing papers authored by Dave Singh

Since Specialization
Citations

This map shows the geographic impact of Dave Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave Singh more than expected).

Fields of papers citing papers by Dave Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave Singh. The network helps show where Dave Singh may publish in the future.

Co-authors

The 25 scholars most cited alongside Dave Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dave Singh Line = papers co-authored together Dave Singh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 565 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Hit paper breakdown →
2018782
2
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
Hit paper breakdown →
2020491
3
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2018411
4
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Hit paper breakdown →
2020394
5
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2017293
6
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2016288
7 2020217
8 2014201
9 2020192
10 2019163
11 2015161
12 2020159
13 2019157
14 2018154
15 2020154
16 2020153
17 2014143
18 2012141
19 2019139
20 2008137

About Dave Singh

Dave Singh is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology, Molecular Biology and Emergency Medical Services, having authored 565 papers that have together received 16.3k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (324 papers), Asthma and respiratory diseases (221 papers), Respiratory Support and Mechanisms (71 papers), Respiratory and Cough-Related Research (69 papers), Inhalation and Respiratory Drug Delivery (68 papers), Pediatric health and respiratory diseases (24 papers), Neonatal Respiratory Health Research (19 papers) and Phosphodiesterase function and regulation (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.1k citations), Physiology (5.8k citations), Emergency Medical Services (828 citations), Issues, ethics and legal aspects (99 citations) and Immunology (1.3k citations). Dave Singh has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Jørgen Vestbo, Alberto Papi, David Halpin, Fernando J. Martínez, Andrew Higham, Simon Lea, Gerard J. Criner, Claus Vogelmeier, Umme Kolsum and Àlvar Agustí. Their work appears in journals such as Respiratory Research, International Journal of COPD, European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact